Solid Biosciences SLDB
NASDAQ SLDB
$7.59 +0.41 (+5.79%)
As of: Nov 11, 2026 · 3:07 PM EST

Solid Biosciences (SLDB) Selling, General & Administrative (2017 - 2026)

Updated

Solid Biosciences (SLDB) posted Selling, General & Administrative of $13.12 million for Q2 2026, up 41.4% from $9.28 million a year earlier and up 17.5% from the prior quarter.

Analysis

Solid Biosciences (SLDB) Selling, General & Administrative (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Solid Biosciences was $44.75 million, up 26.4% year-over-year; for FY2025, it was $38.88 million, up 16.8% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
  • In prior years, Solid Biosciences' Selling, General & Administrative was $33.3 million in FY2024 (+20.0%), $27.75 million in FY2023 (-4.1%), $28.95 million in FY2022 (+6.7%) and $27.14 million in FY2021 (+25.7%).
  • The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q1 2017.
  • On a year-over-year basis, Selling, General & Administrative has increased in each of the last ten quarters, with growth averaging 23.3% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2026, with growth of 41.4%; the weakest was Q4 2023, with a decline of 10.6%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $11.17 million (Q1 2026), $11.27 million (Q4 2025) and $9.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 Solid Biosciences 1.08 Bn -212.24 Mn - 14.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.06 Mn
Jun 30, 2026 13.12 Mn
Mar 31, 2026 11.17 Mn
Dec 31, 2025 11.27 Mn
Sep 30, 2025 9.20 Mn
Jun 30, 2025 9.28 Mn
Mar 31, 2025 9.14 Mn
Dec 31, 2024 9.13 Mn
Sep 30, 2024 7.86 Mn
Jun 30, 2024 8.33 Mn
Mar 31, 2024 7.99 Mn
Dec 31, 2023 6.81 Mn
Sep 30, 2023 6.41 Mn
Jun 30, 2023 7.13 Mn
Mar 31, 2023 7.40 Mn
Dec 31, 2022 7.62 Mn
Sep 30, 2022 7.13 Mn
Jun 30, 2022 6.85 Mn
Mar 31, 2022 7.35 Mn
Dec 31, 2021 7.21 Mn
API Access

Solid Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SLDB&period=max&api_key=YOUR_API_KEY